BioMerieux Gross Profit 2017-2024 | BMXMF

BioMerieux gross profit for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.

  • BioMerieux annual gross profit for 2024 was $2.397B, a 7.66% increase from 2023.
  • BioMerieux annual gross profit for 2023 was $2.227B, a 5.21% increase from 2022.
  • BioMerieux annual gross profit for 2022 was $2.116B, a 8.91% decline from 2021.

BioMerieux Gross Profit 2017-2024 | BMXMF

  • BioMerieux annual gross profit for 2024 was $2.397B, a 7.66% increase from 2023.
  • BioMerieux annual gross profit for 2023 was $2.227B, a 5.21% increase from 2022.
  • BioMerieux annual gross profit for 2022 was $2.116B, a 8.91% decline from 2021.
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$145.3B
CVS Health (CVS)$75.4B
Elevance Health (ELV)$64.4B
Cencora (COR)$55.5B
DiDi Global (DIDIY)$26B
Labcorp Holdings (LH)$21.9B
Natera (NTRA)$18.8B
ICON (ICLR)$15.3B
EUROFINS SCIENT (ERFSF)$14.9B
CochLear (CHEOY)$13.4B
Solventum (SOLV)$12.8B
Medpace Holdings (MEDP)$12.7B
Revvity (RVTY)$11.2B
Viatris (VTRS)$10.9B
Avantor (AVTR)$9.5B
Sonic Healthcare (SKHHY)$9.2B
Charles River Laboratories (CRL)$8.8B
HealthEquity (HQY)$8.3B
Caris Life Sciences,�Inc (CAI)$6.9B
Amplifon S.p.A (AMFPF)$5.4B
Bausch + Lomb (BLCO)$5.1B
BrightSpring Health Services (BTSG)$3.6B
Sotera Health (SHC)$3.5B
Surgery Partners (SGRY)$2.9B
Organon (OGN)$2.6B
Concentras Parent (CON)$2.6B
GeneDx Holdings (WGS)$2.4B
Alignment Healthcare (ALHC)$2.3B
Progyny (PGNY)$2B
PACS (PACS)$1.8B